Endocytosis of the bradykinin-stimulated B 2 receptors is parallel to the transport and subsequent degradation of the ligand. To implement biotechnological applications based on receptormediated transport, one strategy is to conjugate the agonist ligand to a cargo. Alternatively, we studied whether the B 2 receptor can transport large antibody-based cargoes into intact cells and characterized the ensuing endosomal routing. Myc-tagged B 2 receptors (coded by the vector myc- 
Introduction
Following agonist stimulation, a specific Ser-Thr-rich C-terminal domain of the bradykinin B 2 -arrestin and adaptor proteins that mediate agonist-induced endocytosis (Leeb-Lundberg et al., 2005) . The agonist-stimulated B 2 receptors actually transport and translocate bradykinin into the endosomal compartment, where it is degraded (Munoz and Leeb-Lundberg, 1992) . We have recently illustrated B 2 receptormediated transport into intact cells using a bradykinin analog conjugated with a carboxyfluorescein cargo (Gera et al., 2011) ; this agent modelled the endocytic transport, trafficking and intracellular degradation of the peptide ligand.
In the present study, we addressed a novel strategy to exploit receptor-mediated transport for cargoes much heavier than the agonist and showed that receptors encoded by the myc-B 2 R vector mediate the endocytosis of anti-myc monoclonal antibodies in HEK 293a cells stimulated with bradykinin, the N-terminal myc epitope merely representing a model for a receptor extracellular epitope that can be recognized by an antibody present in the extracellular space. The routing of both the fluorescent agonist or antibody-based cargoes theoretically hinges on the function oarrestins, which was verified using a truncated version of myc-tagged B 2 receptors devoid of the domain substrate for the G protein coupled receptor kinases. Further, the trafficking of receptortransported cargoes to early endosome autoantigen 1-or Rab7-positive endosomes and lysosomal or autophagic structures was also addressed. This opens the way to exploiting the particular distribution of a given G protein coupled receptor to confer new types of response to cells. 4
Materials and methods

Drugs and reagents
Cell culture reagents were purchased from Invitrogen. The bradykinin B 2 receptor antagonist LF 16-0687 was a gift from Laboratoires Fournier (Daix, France). Preassembled quantum dot nanocrystals with an average emission wavelength of 705 2 anti-mouse
IgG conjugate) and BSA-Alexa fluor 594 was purchased from Invitrogen (Carlsbad, CA, USA).
All other drugs and reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Cell culture and transfection
A subclone of HEK 293 cells, called HEK 293a, originally obtained from Sigma-Aldrich was supplemented with 10 % FBS, 0.1 % L-glutamine and 0.1 % penicillin-streptomycin. HEK 293a cells were grown until they reached 70 % confluence and were then transfected with one of the myc-B 2 R-coding vectors optionally co-transfected with vectors coding for fusion proteins: -arrestin 1 --arrestin 2 -green fluorescent protein (GFP), or early endosome autoantigen 1 (EEA1)-FYVE-GFP using the EX-Gen 500 transfection reagent (MBI Fermentas Inc., Flameborough, ON, Canada) as recommended by the manufacturer.
Vectors coding for the myc-tagged B 2 receptors (myc-B 2 R) and its truncated version (myc-B 2 R trunc vector) deprived of the substrate domain of the G protein coupled receptor kinase but pharmacologically intact, are described elsewhere (Bawolak et al., 2007; Gera et al., 2011) .
Briefly, truncation of the C-terminus in the myc-B 2 R trunc vector was obtained by mutating Glu 340 in the myc-B 2 R sequence to the stop codon, thus eliminating the 28 C-terminal residues, a 5 sequence that comprises the conserved and phosphorylable Ser-Thr-rich domain (Leeb-Lundberg et al., 2005) . The receptor encoded by myc-B 2 R trunc binds [ 3 H]bradykinin with an affinity identical to that of the myc-tagged B 2 receptor, but its surface expression (B max ) is slightly inferior to that of the non-truncated construction (Gera et al., 2011) . Several plasmids were gifts; the arrestin 2 -GFP fusion protein in pcDNA3 was a kind gift from Dr. M. Bouvier (Université de Montréal, Canada; Bernier et al., 2004) . GFP-Rab7 was graciously given by Dr. M. J.
Tremblay (Université Laval, Canada) and the vector coding for EEA1-FYVE-GFP, by Dr. Tamas Balla (NICHD, NIH, Bethesda, MD, USA). GFP-LC3 labels autophagosomes in mammalian cells (Kabeya et al., 2000) ; the pEGFP-LC3 expression vector for this chimerical protein was a generous gift from Dr. T. Yoshimori (Osaka University, Japan).
Intracellular Ca 2+ mobilization
To detect the possible agonist effect of anti-myc monoclonal antibodies, Fura-2 fluorometry (Invitrogen) was applied as described ).
Antibody Internalization Assay
The assembly of immune complexes at the cell surface was performed at room temperature and preceded the trafficking experiments at 37°C. Intact HEK 293a cells transiently expressing one of the myc-tagged B 2 receptor constructions (and on occasion, other transgenes) were incubated for 30 minutes at room temperature with anti-myc antibody (clone 4A6, Upstate Biotechnology, Lake Placid, NY; dilution 1:1000). Cells were carefully washed with room-temperature phosphate buffered saline, and further labelled with a goat-anti-mouse IgG-Alexa fluor-594 or -488 coupled antibody (Invitrogen). The incubation time and temperature for both primary and 6 secondary antibodies were identical. After the cells were washed once with phosphate buffered saline, they were incubated at 37°C in serum-free culture media (1 % penicillin-streptomycin), optionally in the presence of the antagonist LF 16-0687 (1 µM), for 45 minutes preceding a fifteen-minute treatment with the agonist bradykinin (100 nM). Cells were observed at a 1000 × magnification, using green excitation and red emission filters. In additional experiments, cells
were transfected with GFP--arrestin 2 , GFP-Rab7 or GFP-LC3, before being subjected to labelling; the same protocol was applied. In some experiments, the incubation time was extended to 3 h at 37°C after bradykinin treatment. Other variants of the anti-myc antibody internalization assay are described in Results (immune complexes visualized using Qdots conjugated with secondary anti-mouse IgG antibodies, dilution 1:50 equivalent to a final concentration of 20 nM; unconjugated anti-myc antibodies detected in fixed and permeabilized cells using a fluorophoreconjugated secondary antibody). Qdots were visualized under ultraviolet excitation using an electronic camera that covered all visible wavelengths.
Data analysis
The Photoshop software (version 6, Adobe Systems, Mountain View, CA, USA) was used to 
Results
The glycoprotein encoded by the myc-B 2 R vector is a pharmacologically intact rabbit B 2 receptor construction that has the myc epitope as a N-terminal extracellular extension spatially oriented in such a way that it allows the staining of receptors expressed at the surface of non-permeabilized cells by the monoclonal anti-myc antibody 4A6 (Bawolak et al., 2007) . complexes constructed at the cell surface (Fig. 4) . The receptor construction encoded by myc-B 2 R trunc vector, defective for agonist-induced endocytosis (Gera et al., 2011) , supported the 10 construction of Qdot-containing immune complexes at the surface of cells, but these were not translocated into cells upon bradykinin stimulation (Fig. 4 , statistical analysis Fig. 5 ).
Both systems involving immune complex construction at the cell surface followed by agonistinduced endocytosis were further exploited in cells co-transfected with the myc-B 2 R vector and that coding for another transgene (Fig. 6 ). Co-localization statistics have been made on replicated experiments bearing in mind the specific cycling and basal distribution of each marker. GFP--arrestin 2 , which is cytosolic in resting cells but translocates to endosomes in agonist-stimulated cells , was extensively co-localized with the endocytosed immune complexes consisting of antibody-coated Qdots (Fig. 6 ) upon bradykinin stimulation, indicating that the immune complexes are bound to phosphorylated internalized receptors within 15 min of stimulation. Thus, control cells contained an average of 1.4 ± 0.8 co-localized intracellular particle per cell, whereas 12.9 ± 3.7 were found per agonist-stimulated cell (P<0.001, MannWhitney test, n = 11 and 17 cells, respectively). Unexpectedly, overexpression of this form of arrestin also resulted in a slightly increased agonist-independent endocytosis of immune complexes in repeated experiments, but those presented no co-localization with GFP--arrestin 2 ,
and some cell surface labelling was still apparent. Qdot-containing immune complexes were colocalized with the early endosome marker EEA1-FYVE-GFP (Kutateladze et al., 1999; Grosshans et al., 2006) 15 min after bradykinin stimulation (Fig. 6 ). For this marker, the density of discrete cytosolic particles was similar in both control or bradykinin-stimulated cells ( 
Discussion
An increasing number of conjugates uniting cargoes to agonists of various receptors are being reported in the literature. An example of this is given by the conjugation of substance P with fragments of synthetic antibody (Rizk et al., 2009) , which supports the idea that a G-protein coupled receptor, in this case NK-1, can mediate transport of a cargo larger than its natural ligand. Furthermore, the cargo could escape the endocytic system and seemed to retain its activity. Another example is reported by Diagaradiane et al. (2008) , where EGF was conjugated to Qdots nanocrystals, a strategy allowing higher performance imaging of EGF receptoroverexpressing tumors. Because of the severe loss of affinity for the B 2 receptor exhibited by carboxyfluorescein-aminocaproyl-bradykinin due to the modification of the ligand structure (Gera et al., 2011) , this is probably not the optimal path to increase the variety of cargoes that can be accommodated by the bradykinin B 2 receptor.
Therefore, for further biotechnological applications, we next turned our focus towards antireceptor antibodies and the possibility of using antibodies conjugated with different types of cargoes, which would be internalized while bound to the receptor, itself stimulated by its ligand.
After validating the endocytosis of a single anti-myc antibody bound to the receptor encoded by (Lin et al., 2008) , not counting its polymer and 2 antibodies coatings (average of 3 antibody molecules per particle according to the manufacturer). Nevertheless, it seems that the trafficking of the examined immune complexes is dissociable from that of bradykinin-stimulated myc-tagged B 2 receptors, as the complexes persist in intracellular structures that are partly labelled with GFP-Rab7 after 3 h (Fig. 6) , a time point where bradykinin is disposed of in the serum-containing culture medium (t 1/2 < 10 min) and the B 2 receptor recycled to the cell surface (Bachvarov et al., 2001) . This is analogous to the retention of Qdots coated with transferrin in cells, while the transferrin receptors are rapidly recycled to the cell surface (Tekle et al., 2008) .
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